SAM
ABBV icon

Symphony Asset Management’s AbbVie ABBV Stock Holding History

Symphony Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-16,345
Closed -$1.55M – 180
2018
Q2 		$1.55M Sell
16,345
-346
-2% -$33.8K 0.31% 70
2018
Q1 		$1.58M Sell
16,691
-1,190
-7% -$131K 0.2% 120
2017
Q4 		$1.73M Sell
17,881
-268
-1% -$25.3K 0.18% 131
2017
Q3 		$1.61M Sell
18,149
-135
-0.7% -$10.3K 0.18% 137
2017
Q2 		$1.33M Sell
18,284
-890
-5% -$59.8K 0.15% 146
2017
Q1 		$1.25M Sell
19,174
-630
-3% -$39.6K 0.12% 180
2016
Q4 		$1.24M Sell
19,804
-14,279
-42% -$872K 0.13% 171
2016
Q3 		$2.15M Sell
34,083
-1,819
-5% -$118K 0.22% 121
2016
Q2 		$2.22M Sell
35,902
-34,480
-49% -$2.1M 0.24% 120
2016
Q1 		$4.02M Buy
70,382
+4,692
+7% +$262K 0.43% 57
2015
Q4 		$3.89M Sell
65,690
-24,072
-27% -$1.39M 0.43% 55
2015
Q3 		$4.88M Buy
89,762
+7,031
+8% +$458K 0.59% 36
2015
Q2 		$5.56M Buy
82,731
+45,447
+122% +$2.97M 0.69% 34
2015
Q1 		$2.18M Buy
37,284
+3,386
+10% +$205K 0.25% 94
2014
Q4 		$2.22M Buy
33,898
+47
+0.1% +$2.96K 0.28% 89
2014
Q3 		$1.96M Buy
+33,851
New +$1.88M 0.2% 107
2014
Q2 		– Sell
-52,624
Closed -$2.7M – 402
2014
Q1 		$2.7M Buy
52,624
+3,533
+7% +$179K 0.26% 111
2013
Q4 		$2.59M Buy
49,091
+24,298
+98% +$1.19M 0.19% 109
2013
Q3 		$1.11M Buy
24,793
+456
+2% +$20.2K 0.11% 167
2013
Q2 		$1.01M Buy
+24,337
New +$1.06M 0.1% 187

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Symphony Asset Management's ABBV Position: Q3 2018 in Review

Symphony Asset Management sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 16,345 shares — an estimated $1.55M sold.

Symphony Asset Management first reported a position in ABBV in Q2 2013 and held it in 20 quarters. The position peaked at $5.56M in Q2 2015. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Symphony Asset Management reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
  • Symphony Asset Management sold 16,345 AbbVie shares in Q3 2018, an estimated $1.55M.
  • Symphony Asset Management first reported a position in AbbVie in Q2 2013 and held it in 20 quarters.
  • Symphony Asset Management's AbbVie position peaked at $5.56M in Q2 2015.
  • 1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.